{{Rsnum
|rsid=620861
|Chromosome=8
|position=127323428
|Orientation=minus
|GMAF=0.3751
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=LOC101930033
|Gene_s=LOC101930033
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 38.1 | 47.8 | 14.2
| HCB | 22.6 | 61.3 | 16.1
| JPT | 25.7 | 56.6 | 17.7
| YRI | 49.0 | 39.5 | 11.6
| ASW | 42.1 | 38.6 | 19.3
| CHB | 22.6 | 61.3 | 16.1
| CHD | 34.9 | 45.9 | 19.3
| GIH | 17.8 | 53.5 | 28.7
| LWK | 46.4 | 34.5 | 19.1
| MEX | 41.4 | 43.1 | 15.5
| MKK | 24.5 | 52.9 | 22.6
| TSI | 42.2 | 46.1 | 11.8
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19767752
|Title=Multiple loci on 8q24 associated with prostate cancer susceptibility
}}

{{PMID Auto
|PMID=19767755
|Title=Identification of a new prostate cancer susceptibility locus on chromosome 8q24
|OA=1
}}  (P = 1.3 x 10(-10), heterozygote OR = 1.17, 95% CI 1.10-1.24; homozygote OR = 1.33, 95% CI 1.21-1.45). 
See the entry for [[rs4242382]], which states, "A joint-odds analysis indicates that rs4242382(A;A) individuals have increased prostate cancer odds of 3.15x or 1.77x if they are also carrying 2 or 1 rs620861(C) alleles, respectively."

{{omim
|id=611100
|rsnum=620861
}}

{{PMID Auto
|PMID=21814516
|Title=A Functional Variant at a Prostate Cancer Predisposition Locus at 8q24 Is Associated with PVT1 Expression
|OA=1
}}

{{PMID Auto
|PMID=20690139
|Title=Meta-analysis of genome-wide and replication association studies on prostate cancer.
}}

{{PMID Auto
|PMID=21390317
|Title=Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
|OA=1
}}

{{PMID Auto
|PMID=24224612
|Title=Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a hispanic population
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}